Logo
x

Search

Subscribe Now

ANNOUNCE

Myovant and Pfizer Publish the Results of Relugolix Combination Regimen in P-III LIBERTY Studies in NEJM

Myovant and Pfizer Publish the Results of Relugolix Combination Regimen in P-III LIBERTY Studies in NEJM

  • February 18, 2021
Eli Lilly Reports Results of Lartruvo (olaratumab) in ANNOUNCE P-III Study for Advanced or Metastatic Soft Tissue Sarcoma (STS)

Eli Lilly Reports Results of Lartruvo (olaratumab) in ANNOUNCE P-III Study for Advanced or Metastatic Soft Tissue Sarcoma (STS)

  • January 22, 2019
Bluebird bio and Regeneron Announce R&D and Commercialization Collaboration for Novel Cancer Immune Cell Therapies

Bluebird bio and Regeneron Announce R&D and Commercialization Collaboration for Novel Cancer Immune Cell Therapies

  • August 6, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.